Literature DB >> 8739281

Cytokine production during hemodialysis: effects of dialytic membrane and complement activation.

Y F Lin1, D M Chang, M F Shaio, K C Lu, S H Chyr, B L Li, S D Sheih.   

Abstract

Interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) are closely associated with acute and chronic inflammatory processes in hemodialytic patients. However, the mechanisms concerning cytokine production by monocytes during hemodialysis are still conflicting. With the use of the more specific monoclonal antibody ELISA method, contamination detection and crossover protocol of complement-activating and noncomplement-activating hollow fibers, we were able to confirm augmented II-1 beta production by zymosan-stimulated monocytes with complement-activating hollow fiber as compared to noncomplement-activating hollow fiber before (1,411.9 +/- 865.7 +/- 149.9 pg/ ml/2 x 10(6) monocytes, p < 0.01). at the 15th minute (530.6 +/- 89.1 vs. 247.3 +/- 45.2 pg/ml/2 x 10(6) monocytes, p < 0.01) and at the end of dialysis (1,201.8 +/- 135.1 vs. 707.4 +/- 109.3 pg/ml/2 x 10(6) monocytes, p < 0.01). Similar results were observed with TNF-alpha production. IL-1 beta as well as TNF-alpha production decreased significantly at the 15th min of dialysis, thereafter they increased and approached the baseline levels towards the end of hemodialysis with both hollow fibers. Plasma C3a at the 15th minute correlated positively with postdialysis IL-1 beta and TNF-alpha production, while plasma C3a did not change in patients dialyzed with noncomplement-activating hollow fiber. Complement activation with complement-activating hollow fiber as well as monocyte-membrane interaction with complement-activating and noncomplement-activating hollow fiber might be involved in the pathogenesis of cytokine production during hemodialysis. Uremic toxin removal as well as stimulation of cytokine production inhibitor might contribute to the decreased cytokine production at the 15th minute of hemodialysis and monocyte-membrane interaction with or without complement activation resulted in augmented cytokine production toward the end of hemodialysis with both hollow fibers. We thus concluded that hollow fiber of bioincompatibility triggered much more cytokine production throughout the dialysis procedure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739281     DOI: 10.1159/000169012

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  6 in total

1.  AP-VAS 2012 case report: two patients with rheumatoid arthritis suspected of relapsed microscopic polyangiitis after initiation of dialysis.

Authors:  Mai Sugahara; Takahiro Nishi; Shinji Tanaka; Noriaki Kurita; Keiko Sai; Tatsuya Kano; Kyosuke Nishio; Tokuichiro Sugimoto; Naobumi Mise
Journal:  CEN Case Rep       Date:  2013-07-04

Review 2.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 3.  Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.

Authors:  Ayman A El-Menyar; Jassim Al Suwaidi; David R Holmes
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

Review 4.  The Complement System in Dialysis: A Forgotten Story?

Authors:  Felix Poppelaars; Bernardo Faria; Mariana Gaya da Costa; Casper F M Franssen; Willem J van Son; Stefan P Berger; Mohamed R Daha; Marc A Seelen
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

Review 5.  Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease.

Authors:  Maribel Diaz-Ricart; Sergi Torramade-Moix; Georgina Pascual; Marta Palomo; Ana Belen Moreno-Castaño; Julia Martinez-Sanchez; Manel Vera; Aleix Cases; Gines Escolar
Journal:  Toxins (Basel)       Date:  2020-06-01       Impact factor: 4.546

Review 6.  Monocytes in Uremia.

Authors:  Matthias Girndt; Bogusz Trojanowicz; Christof Ulrich
Journal:  Toxins (Basel)       Date:  2020-05-21       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.